Emily Chang and Andrej Lyshchik, “Current and Emerging Applications for Contrast-Enhanced Ultrasound

Drs. Chang and Lyshchik will discuss the emerging technology of contrast-enhanced ultrasound. Dr. Chang will present examples of cases when contrast-enhanced ultrasound can enhance clinical care. Dr. Lyshchik will describe the evolution of this technology, current indications, future applications and challenges faced by the community.

Dr. Chang is a nephrologist who began investigating various ultrasound techniques for patients with kidney disease during her fellowship. She is currently the PI on a study investigating the use of contrast-enhanced ultrasound (CEUS) in patients with kidney disease and indeterminate or suspicious kidney lesions. She has spoken at national American Institute of Ultrasound in Medicine (AIUM) conferences on the nephrologist’s perspective on contrast-enhanced ultrasound.

Dr. Lyshchik is a radiologist from Thomas Jefferson University with a proven history of excellence in the field of contrast-enhanced ultrasound. As Vice-Chair of American College of Radiology CEUS Liver Imaging Reporting and Data System (LI-RADS) working group and steering committee member, his work was instrumental to the recent FDA approval of a contrast agent for liver imaging. In addition, he is a Vice-Chair of the AIUM Contrast-Enhanced Ultrasound Community, which provides a program for their annual convention. He has delivered multiple talks on CEUS and interventional ultrasound at major radiological and ultrasound meetings in the US. He has recently created the first observership in the United States so that radiologists can obtain training and exposure from an institution with experience in this sector. He is a national leader in the field.